Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06933875

Promoting Palliative Care for People With Heart Failure

This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Heart Failure Cardiovascular Diseases Heart Diseases Palliative Care

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale New Haven Hospital Saint Raphael, New Haven, Connecticut, United States

Loading trial locations.

About this study

Healthcare providers will encounter the tool during the routine care of their hospitalized patients. Patients randomized to the intervention arm will have providers who receive the tool and can complete one post-trial survey. High use providers will also have the opportunity to participate in a survey and 1 post-trial interview. Level 2 providers will participate in one interview.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthcare providers must meet the following criteria:

  • Are an attending physician, fellow, or resident, advanced practice nurse, or physician associate
  • Has ordering privileges
  • Are members of one of the hospitals' admitting teams (e.g., hospitalist service, cardiology service)
  • Anticipate employment at one of the two study sites for the 15-month trial period.

Or

  • Palliative care team member
  • Hospital administrator/quality and safety personnel

Patients of providers enrolled in the study must meet the following criteria for heart failure during hospitalization:

  • Age 18 years of age or older
  • N-terminal pro-B-type natriuretic peptide values of >500 pg/ml
  • Received intravenous diuretics within 24 hours of admission.

Exclusion criteria

  • Pregnant at the time of admission.

Treatment and study plan

Clinical decision support tool

Behavioral

Deliver prognostic information and evidence-based decision support at the point of care

Primary outcomes

  1. Mean System Usability Scale score

    Time frame: up to 15 months

    System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability

  2. Mean Acceptability of Intervention Measure score

    Time frame: up to 15 months

    Acceptability of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher acceptability.

  3. Mean Appropriateness of Intervention Measure score

    Time frame: up to 15 months

    Appropriateness of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher appropriateness.

  4. Mean Feasibility of Intervention Measure score

    Time frame: up to 15 months

    Feasibility of Intervention Measure, 4-item questionnaire. Total score range 1-4. Higher values indicate higher feasibility.

Secondary outcomes

  1. Referral to Specialist Palliative Care

    Time frame: up to 15 months

    Proportion of participants who are referred to Specialist Palliative Care

  2. Consultation by Specialist Palliative Care

    Time frame: up to 15 months

    Proportion of participants who have a completed consultation order by Specialist Palliative Care

  3. Advance Care Plan Documentation

    Time frame: up to 15 months

    Proportion of participants who have a documented Advance Care Plan

  4. Participants enrolled in hospice

    Time frame: up to 15 months

    Proportion of participants enrolled in hospice during hospitalization

  5. Mean hospital length of stay

    Time frame: up to 15 months

    Mean hospital length of stay in days

  6. Participants readmitted to hospital

    Time frame: up to 15 months

    Proportion of participants with 30-day hospital readmission

  7. Change in Code Status

    Time frame: up to 15 months

    Change in code status for comfort measures

Study contacts

Contact information is provided by the study sponsor or research team.

Nathan Wright, MA

CONTACT

[email protected]

Shelli Feder, PhD

CONTACT

[email protected]

937-239-2801

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Official study title

Promoting Palliative Care for People With Heart Failure: The P3HF Pilot Study

Acronym: P3HF

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 18, 2025
Registry last updated
Jul 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.